KMF inhibits NOS and COX-2; it also lowers C-reactive protein (CRP) levels and inhibits pro-inflammatory NFkB, which, in the presence of oxidative stress, upregulates the expression of antioxidant enzymes, which can further lead to cancer progression and chemoresistance [26]. The gene discussed is NFKB1; the disease is cancer.